Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gus Gazzard

Showing results (11-20 of 167) with videos related to

Pageof 17
Sort By:
The Cochrane Database of Systematic Reviews|August 24, 2016
Iridotomy to slow progression of angle-closure glaucomaJimmy T Le, Benjamin Rouse, Gus Gazzard
The Cochrane Database of Systematic Reviews|January 9, 2023
Iridotomy to slow progression of visual field loss in angle-closure glaucomaBenjamin Rouse, Jimmy T Le, Gus Gazzard
Eye (London, England)|May 15, 2020
The COVID-19 pandemic will redefine the future delivery of glaucoma careHari Jayaram, Nicholas G Strouthidis, Gus Gazzard
The British Journal of Ophthalmology|January 30, 2025
Registry-based randomised controlled trials in glaucoma: the time is right?Mitchell Lawlor, Catherine Q Sun, Gus Gazzard
The Cochrane Database of Systematic Reviews|June 14, 2018
Iridotomy to slow progression of visual field loss in angle-closure glaucomaJimmy T Le, Benjamin Rouse, Gus Gazzard
BMJ Open|May 21, 2024
Priorities for health outcomes in glaucoma in an ethnically diverse UK cohort: an observational studyAtika Safitri, Evgenia Konstantakopoulou, Gus Gazzard, et al.
The British Journal of Ophthalmology|January 25, 2007
Laser iridotomy in dark iridesDon Julian de Silva, Gus Gazzard, Paul Foster
Eye (London, England)|April 24, 2023
Treatment expectations in glaucoma: what matters most to patients?Atika Safitri, Evgenia Konstantakopoulou, Kuang Hu, et al.
Ophthalmology|May 17, 2003
Intermediate-term outcome of Baerveldt glaucoma implants in Asian eyesSteve K L Seah, Gus Gazzard, Tin Aung
Ophthalmology. Glaucoma|April 21, 2025
Disease Progression, not Intraocular Pressure, Should Guide Escalation of Treatment in GlaucomaGiovanni Montesano, David F Garway-Heath, Gus Gazzard
Pageof 17

Showing results (11-20 of 167) with videos related to

Sort By:
Pageof 17
The Cochrane Database of Systematic Reviews|August 24, 2016
Iridotomy to slow progression of angle-closure glaucomaJimmy T Le, Benjamin Rouse, Gus Gazzard
The Cochrane Database of Systematic Reviews|January 9, 2023
Iridotomy to slow progression of visual field loss in angle-closure glaucomaBenjamin Rouse, Jimmy T Le, Gus Gazzard
Eye (London, England)|May 15, 2020
The COVID-19 pandemic will redefine the future delivery of glaucoma careHari Jayaram, Nicholas G Strouthidis, Gus Gazzard
The British Journal of Ophthalmology|January 30, 2025
Registry-based randomised controlled trials in glaucoma: the time is right?Mitchell Lawlor, Catherine Q Sun, Gus Gazzard
The Cochrane Database of Systematic Reviews|June 14, 2018
Iridotomy to slow progression of visual field loss in angle-closure glaucomaJimmy T Le, Benjamin Rouse, Gus Gazzard
BMJ Open|May 21, 2024
Priorities for health outcomes in glaucoma in an ethnically diverse UK cohort: an observational studyAtika Safitri, Evgenia Konstantakopoulou, Gus Gazzard, et al.
The British Journal of Ophthalmology|January 25, 2007
Laser iridotomy in dark iridesDon Julian de Silva, Gus Gazzard, Paul Foster
Eye (London, England)|April 24, 2023
Treatment expectations in glaucoma: what matters most to patients?Atika Safitri, Evgenia Konstantakopoulou, Kuang Hu, et al.
Ophthalmology|May 17, 2003
Intermediate-term outcome of Baerveldt glaucoma implants in Asian eyesSteve K L Seah, Gus Gazzard, Tin Aung
Ophthalmology. Glaucoma|April 21, 2025
Disease Progression, not Intraocular Pressure, Should Guide Escalation of Treatment in GlaucomaGiovanni Montesano, David F Garway-Heath, Gus Gazzard
Pageof 17